Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-27 @ 11:40 AM
Study NCT ID:
NCT01324960
Status:
WITHDRAWN
Last Update Posted:
2014-03-20
First Post:
2011-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GFM-Aza-ceplene
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Céline Berthon, MD
Old Organization:
Groupe Francophone des Myelodysplasies
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |